BioMed Research International / 2022 / Article / Tab 4 / Research Article
Coronary Artery Bypass Grafting in Patients with Chronic Kidney Disease: Chronic Kidney Disease Has an Independent Adverse Effect on the Long-Term Outcome of Coronary Artery Bypass Grafting Table 4 Multivariate predictors for mortality in the follow up.
Univariate Multivariate OR (95% CI) valueOR (95% CI) valueAge (years) <0.001 1.05 (1.04–1.06) <0.001 Male sex ( ) 1.19 (0.97–1.46) 0.091 Hypertension ( ) 1.20 (1.01–1.43) 0.042 1.02 (0.85–1.22) 0.853 Hyperlipidemia ( ) 0.62 (0.53–0.72) <0.001 0.72 (0.61–0.85) <0.001 Diabetes ( ) 1.31 (1.13–1.53) <0.001 1.26 (1.07–1.47) 0.004 Peripheral arterial disease ( ) 2.07 (1.73–2.49) <0.001 1.59 (1.32–1.93) <0.001 Previous stroke ( ) 1.85 (1.55–2.21) <0.001 1.25 (1.04–1.51) 0.025 CKD stage ( ) G2 3.55 (1.76–7.16) <0.001 1.30 (0.63–2.68) 0.472 G3 7.52 (3.71–15.25) <0.001 1.95 (0.94–4.06) 0.073 G4 9.73 (4.51–21.02) <0.001 2.82 (1.27–6.24) 0.012 G5 16.36 (7.96–33.63) <0.001 5.78 (2.76–12.09) <0.001 ( )2.38 (1.64–3.46) <0.001 1.65 (1.13–2.42) 0.011 Preoperative AF ( ) 2.17 (1.52–3.10) <0.001 1.65 (1.14–2.38) 0.010 LMT and/or 3VD ( ) 1.23 (1.02–1.49) 0.032 1.28 (1.04–1.57) 0.022 LVEF <40% ( ) 1.82 (1.48–2.24) <0.001 1.75 (1.41–2.18) <0.001 BITA ( ) 0.77 (0.66–0.90) <0.001 0.76 (0.65–0.90) <0.001 SVG ( ) 1.33 (1.14–1.54) <0.001 1.03 (0.88–1.22) 0.702 GEA ( ) 0.81 (0.69–0.94) 0.008 1.07 (0.89–1.28) 0.463 RA ( ) 0.84 (0.70–1.01) 0.072 LAA amputation ( ) 0.74 (0.57–0.94) 0.023 0.71 (0.55–0.92) 0.012
PCI: percutaneous coronary intervention; CKD: chronic kidney disease; MR: mitral regurgitation; AF: atrial fibrillation; LMT: left main trunk; 3VD: three-vessel disease; LVEF: left ventricular ejection fraction; BITA: bilateral internal thoracic artery; SVG: saphenous vein graft; GEA: gastroepiploic artery; RA: radial artery; LAA amputation: left atrial appendage amputation.